Source:http://linkedlifedata.com/resource/pubmed/id/15745109
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001645,
umls-concept:C0014245,
umls-concept:C0019080,
umls-concept:C0023690,
umls-concept:C0175723,
umls-concept:C0199176,
umls-concept:C0205225,
umls-concept:C0242618,
umls-concept:C0282440,
umls-concept:C1096777,
umls-concept:C1514873,
umls-concept:C1521828,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C1705241,
umls-concept:C1705242
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-3-4
|
pubmed:abstractText |
Primary prophylaxis with nonselective beta-blockers in high-risk subjects has been shown to be effective in reducing both esophageal variceal bleeding and mortality. Recently it has been suggested that band ligation may be a better option for primary prophylaxis. We compared nonselective beta-blockers with band ligation in patients with large varices (F2, F3) and elevated hepatic venous wedge pressure gradient (HVWPG, > or = 12 mm Hg). All patients were prospectively followed for variceal bleeding, mortality, and treatment-related complications. Based on previous published studies, we estimated that 90 patients in each arm would be required to show a difference in bleeding rate. The study was prematurely terminated when we realized that our estimated sample size was inadequate to show a difference based on the observed bleeding rate. At the time of termination, 31 patients (Child A, 11; B, 14; C, 6), with a mean HVWPG of 19 +/- 9.1 mm Hg, were randomized to either band ligation (group A; n = 16) or beta-blockers (group B; n = 15). Baseline demographics of both groups were similar and the mean follow-up period was 27.4 +/- 12.9 months. During the follow-up, two patients in group A and one patient in group B had bleeding. Nine patients (29%; group A, six; group B, three; P = ns) died due to non-bleeding-related causes and five (16%) patients (group A, three; group B, two) underwent liver transplantation. Treatment-related complication were minimal in both groups. Despite the selection of high-risk patients, the observed bleeding rate was much lower than anticipated. Based on our observed bleeding rates, 424 patients would be required in each arm to show a difference between band ligation and beta-blocker therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0163-2116
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
407-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15745109-Adrenergic beta-Antagonists,
pubmed-meshheading:15745109-Endoscopy, Gastrointestinal,
pubmed-meshheading:15745109-Esophageal and Gastric Varices,
pubmed-meshheading:15745109-Female,
pubmed-meshheading:15745109-Hemostasis, Endoscopic,
pubmed-meshheading:15745109-Humans,
pubmed-meshheading:15745109-Ligation,
pubmed-meshheading:15745109-Liver Cirrhosis,
pubmed-meshheading:15745109-Male,
pubmed-meshheading:15745109-Middle Aged,
pubmed-meshheading:15745109-Propranolol
|
pubmed:year |
2005
|
pubmed:articleTitle |
A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates.
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. pjthuluv@jhmi.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|